It is estimated that half of the US population experience a fracture by the age of 651. For those patients with fractures treated surgically, 500,000 procedures involve the use of a bone graft2 and this number is expected to rise with an increasingly aging population3. Although bone is one of the few organs that has the capacity to completely heal without scarring, there are instances where the process fails3,4. Depending on the circumstances and quality of treatment, 2-30% of long bone fractures fail, resulting in non-union3,5. While there remains some debate on the definition, pseudoarthrosis, critical-sized or non-union bone injuries generally refers to an injury that does not heal over the natural lifetime of the subject6. For experimental purposes, this duration is shortened to the average time required for complete healing of an average-sized bone injury. Non-union bone lesions occur for numerous reasons, but major factors include extreme trauma resulting in a critically-sized gap, infection, poor angiogenesis, tobacco use, or inhibited osteoregenerative capacity due to disease or age7. Even if non-unions are successfully treated, it can cost in excess of $60,000 per procedure, depending on the type of injury and the approaches employed8.
In moderate cases, autologous bone grafting is employed. This strategy involves recovery of bone from a donor site and implantation at the site of injury. While this approach is extremely effective, the volume of available donor-derived bone is limited and the procedure involves an additional surgery, which results in persistent pain in many patients9,10. In addition, the efficacy of the autologous bone graft is dependent of the health of the patient. Bone substitutes made from synthetic materials or processed cadaveric bone are abundantly available11-13, but they have significant limitations, including poor host-cell adhesion properties, reduced osteoconductivity, and the potential for immune rejection14. There is therefore an urgent need for bone regeneration technologies that are safe, effective and widely available.
Our ability to improve bone regenerative strategies is critically dependent on the ability to mimic serious bone trauma in test animals, but the generation and stabilization of large bone lesions is technically challenging. In most cases, serious long bone trauma is mimicked experimentally by establishing a defect that will not naturally heal. Although it can vary with species15, this is achieved by complete removal of a bone segment that is larger than 1.5 times the diameter of the bone cross-section16. The bone is then stabilized with a metal implant to maintain proper orientation of the fracture edges and allow for mobility. Due to their small size and the fragility of their long bones, establishment of such lesions in mice are beyond the capabilities of most research groups. As such, long bone defect models are confined to rats and larger animals. Nevertheless, mice afford significant research advantages in that they can be genetically modified and bred as immune-compromised strains that do not reject human cells and tissue.
For human cell-based applications, immune-compromised mice are attractive to work with because they are physiologically well-characterized, easy to house, cost effective, and easily analyzed radiologically and histologically. Of paramount importance is that immune-compromised mice do not reject cells from different species including humans. Their small size also permits the testing of very small numbers of cells or volumes of experimental scaffolds in orthopedic applications. Several murine orthopedic models have been reported that afford various degrees of bone stability17,18. Those systems that result in very high levels of stability, such as external fixators and locking plates predominantly heal by intramembranous ossification although endochondral healing has been reported19. In contrast, those that permit some micro- and/or macro-motion, such as those employing unfixed or partially-fixed medullary pins, generally heal with a predominance of endochondral ossification20,21. Delayed union or non-union defects of long bone are particularly difficult to achieve in mice due to the extra level of stabilization required. However, a number of approaches have been reported, including medullary pins with interlocking nails, locking plates and external fixators22. These systems generally work well, but given their complicated design they can be technically challenging to install. For example, Garcia et al.23 devised an elegant interlocking pin system for use in mice, but the procedure involves incisions at two separate sites and extensive modification of the femur to accommodate the pins. These procedures were performed under a dissecting microscope.
Herein, we describe a simple femoral medullary pin with a central collar designed to prevent closing of a 3 mm bone deficit and also delineate the original edges of the defect. While the pin was not fixed to the bone itself, precise sizing of the pin diameter and reaming of the medullary cavity results in sufficient interference to minimize torsional motion (Figure 1). With careful selection of inbred age, gender and strain-matched mice, the result is a highly reproducible hypertrophic non-uniondefect22 which can be easily evaluated radiologically. Moreover regions of interest can be reproducibly defined after micro-computed tomography (µCT) for measurement of de novo bone formation and histomorphological parameters. The pins were prototyped in our laboratory using readily available tools.

Figure 1: Experimental principle. Diagrammatic summary of the segmental defect model. The central 3 mm segment of a 9-10 mm murine femur is excised surgically (left). A 3 mm long, 19 gauge surgical steel tube is passed over a 9 mm long, 22 G stainless steel tube and fixed with adhesive at the exact center (right). The resultant pin is fitted into the medullary canals of the remaining proximal and distal portions of the femur with the 19 G collar replacing the 3 mm segment of bone (below, center).